30 related articles for article (PubMed ID: 38631143)
21. Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinoma.
Zheng N; Zhang S; Wu W; Zhang N; Wang J
Pharmacol Res; 2021 Apr; 166():105507. PubMed ID: 33610718
[TBL] [Abstract][Full Text] [Related]
22. Shedding more light on the role of Midkine in hepatocellular carcinoma: New perspectives on diagnosis and therapy.
Gowhari Shabgah A; Ezzatifar F; Aravindhan S; Olegovna Zekiy A; Ahmadi M; Gheibihayat SM; Gholizadeh Navashenaq J
IUBMB Life; 2021 Apr; 73(4):659-669. PubMed ID: 33625758
[TBL] [Abstract][Full Text] [Related]
23. [Research advances in epithelial - mesenchymal transition in hepatocellular carcinoma].
Yu JX; Liu T; Li QK; Xu MY; Lu LG
Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):389-392. PubMed ID: 28763850
[TBL] [Abstract][Full Text] [Related]
24. TGF-β in epithelial to mesenchymal transition and metastasis of liver carcinoma.
Reichl P; Haider C; Grubinger M; Mikulits W
Curr Pharm Des; 2012; 18(27):4135-47. PubMed ID: 22630087
[TBL] [Abstract][Full Text] [Related]
25. Epithelial-to-Mesenchymal Transition: A Mediator of Sorafenib Resistance in Advanced Hepatocellular Carcinoma.
Mir N; Jayachandran A; Dhungel B; Shrestha R; Steel JC
Curr Cancer Drug Targets; 2017; 17(8):698-706. PubMed ID: 28460616
[TBL] [Abstract][Full Text] [Related]
26. Re-exploration of immunotherapy targeting EMT of hepatocellular carcinoma: Starting from the NF-κB pathway.
Wang S; He Y; Wang J; Luo E
Biomed Pharmacother; 2024 May; 174():116566. PubMed ID: 38631143
[TBL] [Abstract][Full Text] [Related]
27. Individualized precision treatment: Targeting TAM in HCC.
Li Z; Wu T; Zheng B; Chen L
Cancer Lett; 2019 Aug; 458():86-91. PubMed ID: 31129147
[TBL] [Abstract][Full Text] [Related]
28. Multifaceted role of NF-κB in hepatocellular carcinoma therapy: Molecular landscape, therapeutic compounds and nanomaterial approaches.
Gupta R; Kadhim MM; Turki Jalil A; Obayes AM; Aminov Z; Alsaikhan F; Ramírez-Coronel AA; Ramaiah P; Tayyib NA; Luo X
Environ Res; 2023 Jul; 228():115767. PubMed ID: 36966991
[TBL] [Abstract][Full Text] [Related]
29. Regulation of Hepatocellular Carcinoma Epithelial-Mesenchymal Transition Mechanism and Targeted Therapeutic Approaches.
Yüregir Y; Kaçaroğlu D; Yaylacı S
Adv Exp Med Biol; 2024; 1450():93-102. PubMed ID: 37452258
[TBL] [Abstract][Full Text] [Related]
30. Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition.
Li JJ; Liang Q; Sun GC
J Integr Med; 2021 Nov; 19(6):469-477. PubMed ID: 34538644
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
